Showing results (1301-1310 of 1,524) with videos related to
Sort By:
Pageof 153
JACC. Basic to Translational Science|September 1, 2018
A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart FailureDaniel J Lenihan, Sarah A Anderson, Carrie Geisberg Lenneman, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2016
Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART StudyLandon Myer, Tamsin K Phillips, Allison Zerbe, et al.European Journal of Medicinal Chemistry|November 25, 2017
Photoresponsive azo-combretastatin A-4 analoguesShiva K Rastogi, Zhenze Zhao, Scott L Barrett, et al.Journal of the American College of Cardiology|December 10, 2016
Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary HypertensionTufik R Assad, Anna R Hemnes, Emma K Larkin, et al.Plos One|June 26, 2008
A regulatory role for NBS1 in strand-specific mutagenesis during somatic hypermutationLikun Du, Deborah K Dunn-Walters, Krystyna H Chrzanowska, et al.Ophthalmology|January 26, 2018
Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular DegenerationUsha Chakravarthy, Clare C Bailey, Robert L Johnston, et al.ACS Chemical Biology|May 7, 2019
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation ApplicationsCarl C Ward, Jordan I Kleinman, Scott M Brittain, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 11, 2025
Progress in advanced cellular and gene therapies in South Africa and barriers to patient access: A National Consortium paper on behalf of the BloodSA Cell and Gene Therapy working partyC Hendricks, I Viljoen, M Botes, et al.Wellcome Open Research|November 28, 2025
Scalable, open-access and multidisciplinary data integration pipeline for climate-sensitive diseasesAbhishek Dasgupta, Iago Perez-Fernandez, Tuyen Huynh, et al.ACS Chemical Biology|June 23, 2020
A Nimbolide-Based Kinase Degrader Preferentially Degrades Oncogenic BCR-ABLBingqi Tong, Jessica N Spradlin, Luiz F T Novaes, et al.Pageof 153